Brussels Region (BE1)
The region has a population of 1.2 million. In terms of health, the region's strengths lie in its large hospital-hospital hub and the high concentration of people with varied socio-cultural profiles. This provides a breeding ground for clinical trials and collaborations between different scientific disciplines (engineering sciences, life sciences, etc.).
Medical research in the region is recognized in oncology, chronic and neurodegenerative diseases, medical devices and medical engineering. The objective of the strategic field of activity "Personalized Medicine and Wellness" is therefore to capitalize on these assets in order to improve the performance of care and the quality of life of patients. There is a focus on the development of personalized therapies and services, improving the hospital-to-home care chain (e-health) and prevention, by improving the environmental quality of life.
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes
Regional Regional innovation Plan https://innoviris.brussels/sites/default/files/documents/plan_regional_pour_linnovation_2016_2020.pdf
Bridge program on personalised medicine https://innovadm.irisnet.be/fr/documents/bridge-modalites-de-lappel-bridge-sante-et-bien-etre-2017
Join R&D Call Predictive Medicine http://www.irsib.irisnet.be/fr/documents/joint-rd-project-call-formulaire-2019
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
Region represented in : EUREKA/Eurostars/COSME